Novartis AG Total Liabilities 2010-2024 | NVS

Novartis AG total liabilities for the quarter ending December 31, 2024 were $58.120B, a 9.26% increase year-over-year.

  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
  • Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.

Novartis AG Total Liabilities 2010-2024 | NVS

  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
  • Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B